103293,1,Admission,O
103293,1,Date,O
103293,1,:,O
103293,1,[,O
103293,1,**2174-3-18**,O
103293,1,],O
103293,1,Discharge,O
103293,1,Date,O
103293,1,:,O
103293,1,[,O
103293,1,**2174-4-14**,O
103293,1,],O
103293,1,Date,O
103293,1,of,O
103293,1,Birth,O
103293,1,:,O
103293,1,[,O
103293,1,**2095-12-29**,O
103293,1,],O
103293,1,Sex,O
103293,1,:,O
103293,1,M,O
103293,1,Service,O
103293,1,:,O
103293,1,MEDICINE,O
103293,1,Allergies,O
103293,1,:,O
103293,1,No,O
103293,1,Known,O
103293,1,Allergies,O
103293,1,/,O
103293,1,Adverse,O
103293,1,Drug,O
103293,1,Reactions,O
103293,1,Attending,O
103293,1,:,O
103293,1,[,O
103293,1,**First,O
103293,1,Name3,O
103293,1,(,O
103293,1,LF,O
103293,1,),O
103293,1,3984**,O
103293,1,],O
103293,1,Chief,O
103293,1,Complaint,O
103293,1,:,O
103293,1,66,O
103293,1,%,O
103293,1,atypical,O
103293,1,white,O
103293,1,blood,O
103293,1,cells,O
103293,1,and,O
103293,1,low,O
103293,1,platelets,O
103293,1,on,O
103293,1,a,O
103293,1,routine,O
103293,1,CBC,O
103293,1,.,O
103293,1,Major,O
103293,1,Surgical,O
103293,1,or,O
103293,1,Invasive,O
103293,1,Procedure,O
103293,1,:,O
103293,1,Intubation,O
103293,1,History,O
103293,1,of,O
103293,1,Present,O
103293,1,Illness,O
103293,1,:,O
103293,1,History,O
103293,1,of,O
103293,1,Present,O
103293,1,Illness,O
103293,1,:,O
103293,1,The,O
103293,1,pt,O
103293,1,is,O
103293,1,a,O
103293,1,78,O
103293,1,yo,O
103293,1,M,O
103293,1,with,O
103293,1,a,O
103293,1,h/o,O
103293,1,CAD,O
103293,1,",",O
103293,1,HTN,O
103293,1,",",O
103293,1,HL,O
103293,1,",",O
103293,1,DM,O
103293,1,who,O
103293,1,presents,O
103293,1,from,O
103293,1,his,O
103293,1,PCP,O
103293,1,'s,O
103293,1,office,O
103293,1,after,O
103293,1,routine,O
103293,1,CBC,O
103293,1,showed,O
103293,1,66,O
103293,1,%,O
103293,1,atypical,O
103293,1,white,O
103293,1,blood,O
103293,1,cells,O
103293,1,and,O
103293,1,low,O
103293,1,platelets,O
103293,1,on,O
103293,1,a,O
103293,1,routine,O
103293,1,CBC,O
103293,1,.,O
103293,1,He,O
103293,1,initially,O
103293,1,sought,O
103293,1,care,O
103293,1,from,O
103293,1,his,O
103293,1,PCP,O
103293,1,after,O
103293,1,he,O
103293,1,had,O
103293,1,noticed,O
103293,1,that,O
103293,1,he,O
103293,1,had,O
103293,1,noticed,O
103293,1,increased,O
103293,1,bleeding,O
103293,1,from,O
103293,1,the,O
103293,1,site,O
103293,1,of,O
103293,1,a,O
103293,1,removed,O
103293,1,childhood,O
103293,1,skin,O
103293,1,tumor,O
103293,1,which,O
103293,1,had,O
103293,1,been,O
103293,1,severely,O
103293,1,pruritic,O
103293,1,",",O
103293,1,causing,O
103293,1,him,O
103293,1,to,O
103293,1,scratch,O
103293,1,it,O
103293,1,with,O
103293,1,a,O
103293,1,sharp,O
103293,1,back-scratcher,O
103293,1,repeatedly,O
103293,1,.,O
103293,1,The,O
103293,1,PCP,O
103293,1,felt,O
103293,1,the,O
103293,1,patient,O
103293,1,had,O
103293,1,an,O
103293,1,infected,B-Reason
103293,1,cyst,I-Reason
103293,1,and,O
103293,1,started,O
103293,1,abx,B-Drug
103293,1,.,O
103293,1,His,O
103293,1,PCP,O
103293,1,drew,O
103293,1,[,O
103293,1,**Name,O
103293,1,Initial,O
103293,1,(,O
103293,1,PRE,O
103293,1,),O
103293,1,**,O
103293,1,],O
103293,1,CBC,O
103293,1,which,O
103293,1,showed,O
103293,1,66,O
103293,1,%,O
103293,1,atypical,O
103293,1,white,O
103293,1,cells,O
103293,1,and,O
103293,1,thrombocytopenia,O
103293,1,with,O
103293,1,a,O
103293,1,normal,O
103293,1,white,O
103293,1,cell,O
103293,1,count,O
103293,1,and,O
103293,1,hematocrit,O
103293,1,.,O
103293,1,He,O
103293,1,then,O
103293,1,ordered,O
103293,1,immunophenotyping,O
103293,1,which,O
103293,1,is,O
103293,1,pending,O
103293,1,",",O
103293,1,and,O
103293,1,sent,O
103293,1,the,O
103293,1,patient,O
103293,1,to,O
103293,1,the,O
103293,1,ED,O
103293,1,.,O
103293,1,On,O
103293,1,review,O
103293,1,of,O
103293,1,systems,O
103293,1,",",O
103293,1,the,O
103293,1,patient,O
103293,1,also,O
103293,1,notes,O
103293,1,more,O
103293,1,malaise,O
103293,1,and,O
103293,1,dyspnea,O
103293,1,on,O
103293,1,exertion,O
103293,1,over,O
103293,1,the,O
103293,1,last,O
103293,1,month,O
103293,1,",",O
103293,1,as,O
103293,1,well,O
103293,1,as,O
103293,1,intermittently,O
103293,1,blood,O
103293,1,streaked,O
103293,1,stools,O
103293,1,and,O
103293,1,melena,O
103293,1,.,O
103293,1,In,O
103293,1,the,O
103293,1,ED,O
103293,1,",",O
103293,1,the,O
103293,1,patient,O
103293,1,was,O
103293,1,noted,O
103293,1,to,O
103293,1,have,O
103293,1,no,O
103293,1,evidence,O
103293,1,of,O
103293,1,bleeding,O
103293,1,but,O
103293,1,labs,O
103293,1,concerning,O
103293,1,for,O
103293,1,DIC,O
103293,1,and,O
103293,1,tumor,O
103293,1,lysis,O
103293,1,.,O
103293,1,He,O
103293,1,was,O
103293,1,seen,O
103293,1,by,O
103293,1,the,O
103293,1,heme-onc,O
103293,1,consult,O
103293,1,fellow,O
103293,1,.,O
103293,1,He,O
103293,1,was,O
103293,1,given,O
103293,1,2,O
103293,1,amps,O
103293,1,of,O
103293,1,bicarb,B-Drug
103293,1,with,I-Drug
103293,1,D5W,I-Drug
103293,1,at,O
103293,1,100,O
103293,1,cc/hr,O
103293,1,.,O
103293,1,He,O
103293,1,was,O
103293,1,given,O
103293,2,10u,O
103293,2,of,O
103293,2,cryoprecpitate,B-Drug
103293,2,and,O
103293,2,transfused,O
103293,2,platelets,B-Drug
103293,2,.,O
103293,2,He,O
103293,2,also,O
103293,2,received,O
103293,2,50,O
103293,2,mg,O
103293,2,PO,O
103293,2,of,O
103293,2,all-trans,B-Drug
103293,2,retinoic,I-Drug
103293,2,acid,I-Drug
103293,2,.,O
103293,2,Review,O
103293,2,of,O
103293,2,Systems,O
103293,2,:,O
103293,2,(,O
103293,2,+,O
103293,2,),O
103293,2,recent,O
103293,2,chills,O
103293,2,",",O
103293,2,headaches,O
103293,2,",",O
103293,2,(,O
103293,2,-,O
103293,2,),O
103293,2,Review,O
103293,2,of,O
103293,2,Systems,O
103293,2,:,O
103293,2,GEN,O
103293,2,:,O
103293,2,No,O
103293,2,night,O
103293,2,sweats,O
103293,2,",",O
103293,2,recent,O
103293,2,weight,O
103293,2,loss,O
103293,2,or,O
103293,2,gain,O
103293,2,.,O
103293,2,HEENT,O
103293,2,:,O
103293,2,No,O
103293,2,headache,O
103293,2,",",O
103293,2,sinus,O
103293,2,tenderness,O
103293,2,",",O
103293,2,rhinorrhea,O
103293,2,or,O
103293,2,congestion,O
103293,2,.,O
103293,2,CV,O
103293,2,:,O
103293,2,No,O
103293,2,chest,O
103293,2,pain,O
103293,2,or,O
103293,2,tightness,O
103293,2,",",O
103293,2,palpitations,O
103293,2,.,O
103293,2,PULM,O
103293,2,:,O
103293,2,No,O
103293,2,cough,O
103293,2,",",O
103293,2,or,O
103293,2,wheezing,O
103293,2,.,O
103293,2,GI,O
103293,2,:,O
103293,2,No,O
103293,2,nausea,O
103293,2,",",O
103293,2,vomiting,O
103293,2,",",O
103293,2,diarrhea,O
103293,2,",",O
103293,2,constipation,O
103293,2,or,O
103293,2,abdominal,O
103293,2,pain,O
103293,2,.,O
103293,2,No,O
103293,2,recent,O
103293,2,change,O
103293,2,in,O
103293,2,bowel,O
103293,2,habits,O
103293,2,.,O
103293,2,GUI,O
103293,2,:,O
103293,2,No,O
103293,2,dysuria,O
103293,2,or,O
103293,2,change,O
103293,2,in,O
103293,2,bladder,O
103293,2,habits,O
103293,2,.,O
103293,2,MSK,O
103293,2,:,O
103293,2,No,O
103293,2,arthritis,O
103293,2,",",O
103293,2,arthralgias,O
103293,2,",",O
103293,2,or,O
103293,2,myalgias,O
103293,2,.,O
103293,2,DERM,O
103293,2,:,O
103293,2,No,O
103293,2,rashes,O
103293,2,or,O
103293,2,skin,O
103293,2,breakdown,O
103293,2,.,O
103293,2,NEURO,O
103293,2,:,O
103293,2,No,O
103293,2,numbness/tingling,O
103293,2,in,O
103293,2,extremities,O
103293,2,.,O
103293,2,PSYCH,O
103293,2,:,O
103293,2,No,O
103293,2,feelings,O
103293,2,of,O
103293,2,depression,O
103293,2,or,O
103293,2,anxiety,O
103293,2,.,O
103293,2,All,O
103293,2,other,O
103293,2,review,O
103293,2,of,O
103293,2,systems,O
103293,2,negative,O
103293,2,.,O
103293,2,Past,O
103293,2,Medical,O
103293,2,History,O
103293,2,:,O
103293,2,Past,O
103293,2,Oncologic,O
103293,2,History,O
103293,2,:,O
103293,2,Received,O
103293,2,radiation,O
103293,2,as,O
103293,2,child,O
103293,2,to,O
103293,2,back,O
103293,2,for,O
103293,2,'',O
103293,2,tumors,O
103293,2,'',O
103293,2,.,O
103293,2,.,O
103293,2,Other,O
103293,2,Past,O
103293,2,Medical,O
103293,2,History,O
103293,2,:,O
103293,2,CAD,O
103293,2,-,O
103293,2,stable,O
103293,2,angina,O
103293,2,Gout,O
103293,2,-,O
103293,2,no,O
103293,2,recent,O
103293,2,flares,O
103293,2,HTN,O
103293,2,PUD,O
103293,2,-,O
103293,2,last,O
103293,2,EGD,O
103293,2,[,O
103293,2,**2169**,O
103293,2,],O
103293,2,Type,B-Reason
103293,2,II,I-Reason
103293,2,DM,I-Reason
103293,2,-,O
103293,2,A1c,O
103293,2,6.2,O
103293,2,%,O
103293,2,on,O
103293,2,metformin,B-Drug
103293,2,Social,O
103293,2,History,O
103293,2,:,O
103293,2,He,O
103293,2,lives,O
103293,2,with,O
103293,2,his,O
103293,2,partner,O
103293,2,",",O
103293,2,[,O
103293,2,**Name,O
103293,2,(,O
103293,2,NI,O
103293,2,),O
103293,2,**,O
103293,2,],O
103293,2,",",O
103293,2,who,O
103293,2,he,O
103293,2,has,O
103293,2,been,O
103293,2,with,O
103293,2,for,O
103293,2,over,O
103293,2,50yrs,O
103293,2,and,O
103293,2,married,O
103293,2,to,O
103293,2,for,O
103293,2,6,O
103293,2,yrs,O
103293,2,.,O
103293,2,He,O
103293,2,has,O
103293,2,one,O
103293,2,brother,O
103293,2,who,O
103293,2,his,O
103293,2,is,O
103293,2,not,O
103293,2,in,O
103293,2,contact,O
103293,2,with,O
103293,2,and,O
103293,2,no,O
103293,2,children,O
103293,2,.,O
103293,2,He,O
103293,2,has,O
103293,2,had,O
103293,2,several,O
103293,2,prior,O
103293,2,employments,O
103293,2,",",O
103293,2,including,O
103293,2,journalism,O
103293,2,",",O
103293,2,dance,O
103293,2,",",O
103293,2,stage,O
103293,2,management,O
103293,2,",",O
103293,2,and,O
103293,2,travel,O
103293,2,reporter,O
103293,2,.,O
103293,2,He,O
103293,2,also,O
103293,2,worked,O
103293,2,as,O
103293,2,a,O
103293,2,silver,O
103293,2,[,O
103293,2,**Doctor,O
103293,2,Last,O
103293,2,Name,O
103293,2,**,O
103293,2,],O
103293,2,when,O
103293,2,he,O
103293,2,was,O
103293,2,exposed,O
103293,2,to,O
103293,2,sulfer,O
103293,2,products,O
103293,2,.,O
103293,2,He,O
103293,2,has,O
103293,2,travelled,O
103293,2,extensively,O
103293,2,.,O
103293,2,Last,O
103293,2,HIV,O
103293,2,negative,O
103293,2,1,O
103293,2,year,O
103293,2,ago,O
103293,2,",",O
103293,3,Hepatitis,O
103293,3,negative,O
103293,3,in,O
103293,3,the,O
103293,3,distant,O
103293,3,past,O
103293,3,.,O
103293,3,He,O
103293,3,has,O
103293,3,a,O
103293,3,distant,O
103293,3,history,O
103293,3,of,O
103293,3,smoking,O
103293,3,for,O
103293,3,1,O
103293,3,year,O
103293,3,.,O
103293,3,He,O
103293,3,has,O
103293,3,a,O
103293,3,history,O
103293,3,of,O
103293,3,'heavy,O
103293,3,',O
103293,3,drinking,O
103293,3,with,O
103293,3,scotch,O
103293,3,",",O
103293,3,but,O
103293,3,now,O
103293,3,drinks,O
103293,3,only,O
103293,3,wine,O
103293,3,with,O
103293,3,dinner,O
103293,3,per,O
103293,3,his,O
103293,3,report,O
103293,3,.,O
103293,3,Smokes,O
103293,3,occasional,O
103293,3,marijuana,O
103293,3,",",O
103293,3,and,O
103293,3,distant,O
103293,3,history,O
103293,3,of,O
103293,3,experimenting,O
103293,3,with,O
103293,3,other,O
103293,3,drugs,O
103293,3,.,O
103293,3,Family,O
103293,3,History,O
103293,3,:,O
103293,3,Father,O
103293,3,died,O
103293,3,of,O
103293,3,MI,O
103293,3,at,O
103293,3,51,O
103293,3,.,O
103293,3,Mother,O
103293,3,of,O
103293,3,throat,O
103293,3,cancer,O
103293,3,in,O
103293,3,early,O
103293,3,80s,O
103293,3,after,O
103293,3,long,O
103293,3,smoking,O
103293,3,and,O
103293,3,alcohol,O
103293,3,history,O
103293,3,.,O
103293,3,His,O
103293,3,brother,O
103293,3,is,O
103293,3,apparently,O
103293,3,healthy,O
103293,3,.,O
103293,3,Physical,O
103293,3,Exam,O
103293,3,:,O
103293,3,On,O
103293,3,Admission,O
103293,3,:,O
103293,3,VS,O
103293,3,:,O
103293,3,T,O
103293,3,:,O
103293,3,100.6,O
103293,3,F,O
103293,3,",",O
103293,3,BP,O
103293,3,130/78,O
103293,3,",",O
103293,3,HR,O
103293,3,96,O
103293,3,",",O
103293,3,RR,O
103293,3,20,O
103293,3,",",O
103293,3,O2sat,O
103293,3,100,O
103293,3,%,O
103293,3,on,O
103293,3,RA,O
103293,3,GEN,O
103293,3,:,O
103293,3,AOx3,O
103293,3,",",O
103293,3,NAD,O
103293,3,HEENT,O
103293,3,:,O
103293,3,PERRLA,O
103293,3,.,O
103293,3,MMM,O
103293,3,.,O
103293,3,no,O
103293,3,LAD,O
103293,3,.,O
103293,3,no,O
103293,3,JVD,O
103293,3,.,O
103293,3,neck,O
103293,3,supple,O
103293,3,.,O
103293,3,No,O
103293,3,cervical,O
103293,3,",",O
103293,3,supraclavicular,O
103293,3,",",O
103293,3,or,O
103293,3,axillary,O
103293,3,LAD,O
103293,3,Cards,O
103293,3,:,O
103293,3,RRR,O
103293,3,.,O
103293,3,S1/S2,O
103293,3,normal,O
103293,3,.,O
103293,3,no,O
103293,3,murmurs/gallops/rubs,O
103293,3,.,O
103293,3,Pulm,O
103293,3,:,O
103293,3,No,O
103293,3,dullness,O
103293,3,to,O
103293,3,percussion,O
103293,3,",",O
103293,3,CTAB,O
103293,3,no,O
103293,3,crackles,O
103293,3,or,O
103293,3,wheezes,O
103293,3,Abd,O
103293,3,:,O
103293,3,BS+,O
103293,3,",",O
103293,3,soft,O
103293,3,",",O
103293,3,NT,O
103293,3,",",O
103293,3,no,O
103293,3,rebound/guarding,O
103293,3,",",O
103293,3,no,O
103293,3,HSM,O
103293,3,",",O
103293,3,no,O
103293,3,[,O
103293,3,**Doctor,O
103293,3,Last,O
103293,3,Name,O
103293,3,515**,O
103293,3,],O
103293,3,sign,O
103293,3,Extremities,O
103293,3,:,O
103293,3,wwp,O
103293,3,",",O
103293,3,no,O
103293,3,edema,O
103293,3,.,O
103293,3,DPs,O
103293,3,",",O
103293,3,PTs,O
103293,3,2+,O
103293,3,.,O
103293,3,Skin,O
103293,3,:,O
103293,3,excoriations,O
103293,3,in,O
103293,3,R,O
103293,3,axilla,O
103293,3,.,O
103293,3,scab,O
103293,3,centrally,O
103293,3,located,O
103293,3,on,O
103293,3,central,O
103293,3,thoracic,O
103293,3,back,O
103293,3,with,O
103293,3,mild,O
103293,3,surrounding,O
103293,3,erythema,O
103293,3,but,O
103293,3,no,O
103293,3,purulent,O
103293,3,drainage,O
103293,3,or,O
103293,3,warmth,O
103293,3,though,O
103293,3,somewhat,O
103293,3,tender,O
103293,3,Neuro,O
103293,3,:,O
103293,3,CNs,O
103293,3,II-XII,O
103293,3,intact,O
103293,3,.,O
103293,3,5/5,O
103293,3,strength,O
103293,3,globally,O
103293,3,.,O
103293,3,sensation,O
103293,3,intact,O
103293,3,to,O
103293,3,LT,O
103293,3,",",O
103293,3,gait,O
103293,3,WNL,O
103293,3,.,O
103293,3,Pertinent,O
103293,3,Results,O
103293,3,:,O
103293,3,Admission,O
103293,3,labs,O
103293,3,:,O
103293,3,[,O
103293,3,**2174-3-17**,O
103293,3,],O
103293,3,04:55PM,O
103293,3,BLOOD,O
103293,3,WBC-5.3,O
103293,3,RBC-3.96*,O
103293,3,Hgb-11.9*,O
103293,3,Hct-32.8*,O
103293,3,MCV-83,O
103293,3,MCH-30.2,O
103293,3,MCHC-36.4*,O
103293,3,RDW-14.9,O
103293,3,Plt,O
103293,3,Ct-22*,O
103293,3,#,O
103293,3,[,O
103293,3,**2174-3-18**,O
103293,3,],O
103293,3,10:00AM,O
103293,3,BLOOD,O
103293,3,PT-16.1*,O
103293,3,PTT-22.0,O
103293,3,INR,O
103293,3,(,O
103293,3,PT,O
103293,3,),O
103293,3,-1.4*,O
103293,3,[,O
103293,3,**2174-3-17**,O
103293,3,],O
103293,3,04:55PM,O
103293,3,BLOOD,O
103293,3,UreaN-22*,O
103293,3,Creat-1.2,O
103293,3,Na-137,O
103293,3,K-4.5,O
103293,3,Cl-99,O
103293,3,HCO3-28,O
103293,3,AnGap-15,O
103293,3,[,O
103293,3,**2174-3-17**,O
103293,3,],O
103293,3,04:55PM,O
103293,3,BLOOD,O
103293,3,Glucose-143*,O
103293,3,[,O
103293,3,**2174-3-18**,O
103293,3,],O
103293,3,05:32PM,O
103293,3,BLOOD,O
103293,3,ALT-24,O
103293,3,AST-33,O
103293,3,LD,O
103293,3,(,O
103293,4,LDH,O
103293,4,),O
103293,4,-483*,O
103293,4,AlkPhos-68,O
103293,4,TotBili-1.0,O
103293,4,Brief,O
103293,4,Hospital,O
103293,4,Course,O
103293,4,:,O
103293,4,78,O
103293,4,yo,O
103293,4,male,O
103293,4,with,O
103293,4,distant,O
103293,4,history,O
103293,4,of,O
103293,4,stable,O
103293,4,angina,O
103293,4,",",O
103293,4,new,O
103293,4,diagnosis,O
103293,4,of,O
103293,4,acute,O
103293,4,promyelocytic,O
103293,4,leukemia,O
103293,4,",",O
103293,4,transferred,O
103293,4,to,O
103293,4,the,O
103293,4,ICU,O
103293,4,with,O
103293,4,tachycardia,O
103293,4,after,O
103293,4,ATRA,O
103293,4,treatment,O
103293,4,on,O
103293,4,the,O
103293,4,hematology,O
103293,4,malignancy,O
103293,4,floor,O
103293,4,",",O
103293,4,with,O
103293,4,DIC,O
103293,4,",",O
103293,4,pulmonary,O
103293,4,edema,O
103293,4,",",O
103293,4,and,O
103293,4,delirium,O
103293,4,.,O
103293,4,.,O
103293,4,#,O
103293,4,APML,B-Reason
103293,4,:,O
103293,4,He,O
103293,4,was,O
103293,4,diagnosed,O
103293,4,with,O
103293,4,APML,O
103293,4,with,O
103293,4,56,O
103293,4,%,O
103293,4,blasts,O
103293,4,on,O
103293,4,differential,O
103293,4,[,O
103293,4,**2174-3-18**,O
103293,4,],O
103293,4,.,O
103293,4,He,O
103293,4,was,O
103293,4,treated,O
103293,4,with,O
103293,4,ATRA,B-Drug
103293,4,and,O
103293,4,subsequently,O
103293,4,suffered,O
103293,4,from,O
103293,4,ATRA,B-ADE
103293,4,syndrome,I-ADE
103293,4,with,O
103293,4,an,O
103293,4,acute,B-ADE
103293,4,elevation,I-ADE
103293,4,in,I-ADE
103293,4,his,I-ADE
103293,4,WBC,I-ADE
103293,4,to,I-ADE
103293,4,>,I-ADE
103293,4,50,I-ADE
103293,4,K,I-ADE
103293,4,.,O
103293,4,He,O
103293,4,had,O
103293,4,significant,O
103293,4,pulmonary,O
103293,4,leak,O
103293,4,.,O
103293,4,He,O
103293,4,was,O
103293,4,treated,O
103293,4,with,O
103293,4,ATRA,B-Drug
103293,4,throughout,O
103293,4,and,O
103293,4,received,O
103293,4,Idarubicin,B-Drug
103293,4,which,O
103293,4,had,O
103293,4,to,O
103293,4,be,O
103293,4,stopped,O
103293,4,secondary,O
103293,4,to,O
103293,4,elevated,B-ADE
103293,4,bilirubin,I-ADE
103293,4,.,O
103293,4,His,O
103293,4,blasts,O
103293,4,and,O
103293,4,WBC,O
103293,4,subsequently,O
103293,4,decreased,O
103293,4,",",O
103293,4,and,O
103293,4,on,O
103293,4,smear,O
103293,4,[,O
103293,4,**2174-4-4**,O
103293,4,],O
103293,4,his,O
103293,4,myelocytes,O
103293,4,showed,O
103293,4,differentiation,O
103293,4,with,O
103293,4,improving,O
103293,4,status,O
103293,4,of,O
103293,4,his,O
103293,4,leukemia,O
103293,4,.,O
103293,4,ATRA,B-Drug
103293,4,was,O
103293,4,continued,O
103293,4,throughout,O
103293,4,his,O
103293,4,hospitalization,O
103293,4,.,O
103293,4,As,O
103293,4,a,O
103293,4,consequence,O
103293,4,of,O
103293,4,treatment,O
103293,4,",",O
103293,4,his,O
103293,4,course,O
103293,4,was,O
103293,4,complicated,O
103293,4,by,O
103293,4,tumor,B-ADE
103293,4,lysis,I-ADE
103293,4,syndrome,I-ADE
103293,4,with,O
103293,4,his,O
103293,4,uric,O
103293,4,acid,O
103293,4,peaking,O
103293,4,above,O
103293,4,10,O
103293,4,",",O
103293,4,with,O
103293,4,a,O
103293,4,change,O
103293,4,an,O
103293,4,increase,O
103293,4,in,O
103293,4,creatinine,O
103293,4,to,O
103293,4,2.5,O
103293,4,initially,O
103293,4,and,O
103293,4,subsequently,O
103293,4,higher,O
103293,4,as,O
103293,4,described,O
103293,4,below,O
103293,4,.,O
103293,4,He,O
103293,4,was,O
103293,4,treated,O
103293,4,with,O
103293,4,allopurinol,B-Drug
103293,4,initially,O
103293,4,",",O
103293,4,and,O
103293,4,required,O
103293,4,a,O
103293,4,1x,O
103293,4,dose,O
103293,4,of,O
103293,4,Rasburicase,B-Drug
103293,4,which,O
103293,4,led,O
103293,4,to,O
103293,4,the,O
103293,4,resolution,O
103293,4,of,O
103293,4,his,O
103293,4,TLS,O
103293,4,.,O
103293,4,He,O
103293,4,was,O
103293,4,maintained,O
103293,4,on,O
103293,4,his,O
103293,4,allopurinol,B-Drug
103293,4,for,O
103293,4,continued,O
103293,4,treatment,O
103293,4,.,O
103293,4,.,O
103293,4,#,O
103293,4,Respiratory,O
103293,4,Failure,O
103293,4,:,O
103293,4,Likely,O
103293,4,multifactorial,O
103293,4,in,O
103293,4,the,O
103293,4,setting,O
103293,4,of,O
103293,4,pulmonary,B-ADE
103293,4,leak,I-ADE
103293,4,from,O
103293,4,ATRA,B-Drug
103293,4,and,O
103293,4,likely,O
103293,4,alveolar,O
103293,4,hemorrhage,O
103293,4,.,O
103293,4,His,O
103293,4,fluid,O
103293,4,balance,O
103293,4,reached,O
103293,4,a,O
103293,4,peak,O
103293,4,of,O
103293,4,27L,O
103293,4,positive,O
103293,4,secondary,O
103293,4,to,O
103293,4,his,O
103293,4,blood,O
103293,4,product,O
103293,4,requirement,O
103293,4,.,O
103293,4,He,O
103293,4,initially,O
103293,4,required,O
103293,4,a,O
103293,4,PEEP,O
103293,4,of,O
103293,4,22,O
103293,4,with,O
103293,4,FiO2,O
103293,4,of,O
103293,4,100,O
103293,4,%,O
103293,4,.,O
103293,4,Over,O
103293,4,the,O
103293,4,course,O
103293,4,of,O
103293,4,10,O
103293,4,days,O
103293,4,he,O
103293,4,was,O
103293,4,able,O
103293,4,to,O
103293,4,be,O
103293,4,weaned,O
103293,4,down,O
103293,4,with,O
103293,4,the,O
103293,4,assistance,O
103293,4,of,O
103293,4,CVVH,O
103293,4,for,O
103293,4,fluid,O
103293,4,overload,O
103293,4,to,O
103293,4,pressure,O
103293,4,support,O
103293,4,of,O
103293,4,[,O
103293,4,**5-19**,O
103293,4,],O
103293,4,.,O
103293,4,His,O
103293,4,mental,O
103293,5,status,O
103293,5,was,O
103293,5,the,O
103293,5,largest,O
103293,5,obstacle,O
103293,5,to,O
103293,5,extubation,O
103293,5,and,O
103293,5,he,O
103293,5,was,O
103293,5,taken,O
103293,5,for,O
103293,5,tracheotomy,O
103293,5,tube,O
103293,5,placement,O
103293,5,by,O
103293,5,Thoracic,O
103293,5,Surgery,O
103293,5,on,O
103293,5,[,O
103293,5,**2174-4-8**,O
103293,5,],O
103293,5,.,O
103293,5,He,O
103293,5,tolerated,O
103293,5,the,O
103293,5,procedure,O
103293,5,well,O
103293,5,",",O
103293,5,and,O
103293,5,was,O
103293,5,able,O
103293,5,to,O
103293,5,be,O
103293,5,transitioned,O
103293,5,to,O
103293,5,trach,O
103293,5,collar,O
103293,5,starting,O
103293,5,on,O
103293,5,[,O
103293,5,**2174-4-10**,O
103293,5,],O
103293,5,for,O
103293,5,periods,O
103293,5,of,O
103293,5,time,O
103293,5,.,O
103293,5,.,O
103293,5,#,O
103293,5,DIC,O
103293,5,:,O
103293,5,Due,O
103293,5,to,O
103293,5,his,O
103293,5,APML,O
103293,5,",",O
103293,5,he,O
103293,5,developed,O
103293,5,DIC,O
103293,5,evidenced,O
103293,5,by,O
103293,5,active,O
103293,5,bleeding,O
103293,5,from,O
103293,5,his,O
103293,5,ET,O
103293,5,tube,O
103293,5,",",O
103293,5,his,O
103293,5,OG,O
103293,5,tube,O
103293,5,",",O
103293,5,his,O
103293,5,stool,O
103293,5,and,O
103293,5,urine,O
103293,5,.,O
103293,5,He,O
103293,5,had,O
103293,5,acute,O
103293,5,drops,O
103293,5,in,O
103293,5,fibrinogen,O
103293,5,",",O
103293,5,increase,O
103293,5,in,O
103293,5,LDH,O
103293,5,and,O
103293,5,increase,O
103293,5,in,O
103293,5,bilirubin,O
103293,5,.,O
103293,5,He,O
103293,5,was,O
103293,5,supported,O
103293,5,through,O
103293,5,this,O
103293,5,with,O
103293,5,massive,O
103293,5,transfustions,O
103293,5,requiring,O
103293,5,18,O
103293,5,units,O
103293,5,of,O
103293,5,PRBCs,B-Drug
103293,5,",",O
103293,5,35,O
103293,5,units,O
103293,5,of,O
103293,5,platelets,B-Drug
103293,5,",",O
103293,5,5,O
103293,5,units,O
103293,5,of,O
103293,5,FFP,B-Drug
103293,5,",",O
103293,5,and,O
103293,5,24,O
103293,5,units,O
103293,5,of,O
103293,5,cryoprecipitate,B-Drug
103293,5,.,O
103293,5,He,O
103293,5,was,O
103293,5,intubated,O
103293,5,due,O
103293,5,hypoxia,O
103293,5,and,O
103293,5,increased,O
103293,5,work,O
103293,5,of,O
103293,5,breathing,O
103293,5,on,O
103293,5,[,O
103293,5,**2174-3-26**,O
103293,5,],O
103293,5,.,O
103293,5,His,O
103293,5,CXR,O
103293,5,after,O
103293,5,intubation,O
103293,5,showed,O
103293,5,a,O
103293,5,fluffy,O
103293,5,infiltrate,O
103293,5,suggestive,O
103293,5,of,O
103293,5,either,O
103293,5,ARDS,O
103293,5,or,O
103293,5,hemorrhage,O
103293,5,(,O
103293,5,likely,O
103293,5,both,O
103293,5,),O
103293,5,.,O
103293,5,Due,O
103293,5,to,O
103293,5,his,O
103293,5,subdural,O
103293,5,hematomas,O
103293,5,",",O
103293,5,he,O
103293,5,was,O
103293,5,transfused,O
103293,5,to,O
103293,5,goals,O
103293,5,of,O
103293,5,Hct,O
103293,5,>,O
103293,5,30,O
103293,5,",",O
103293,5,plts,O
103293,5,>,O
103293,5,100,O
103293,5,",",O
103293,5,fibrinogen,O
103293,5,>,O
103293,5,175,O
103293,5,",",O
103293,5,and,O
103293,5,INR,O
103293,5,<,O
103293,5,1.6,O
103293,5,.,O
103293,5,Once,O
103293,5,the,O
103293,5,DIC,O
103293,5,resolved,O
103293,5,",",O
103293,5,his,O
103293,5,goals,O
103293,5,changed,O
103293,5,to,O
103293,5,Hct,O
103293,5,>,O
103293,5,25,O
103293,5,",",O
103293,5,plts,O
103293,5,>,O
103293,5,20,O
103293,5,",",O
103293,5,fibrinogen,O
103293,5,>,O
103293,5,100,O
103293,5,",",O
103293,5,and,O
103293,5,INR,O
103293,5,<,O
103293,5,1.6,O
103293,5,.,O
103293,5,.,O
103293,5,#,O
103293,5,Toxic,B-Reason
103293,5,Metabolic,I-Reason
103293,5,Encephalopathy,I-Reason
103293,5,:,O
103293,5,He,O
103293,5,started,O
103293,5,experiencing,O
103293,5,a,O
103293,5,decline,O
103293,5,in,O
103293,5,mental,O
103293,5,status,O
103293,5,2,O
103293,5,days,O
103293,5,prior,O
103293,5,to,O
103293,5,intubation,O
103293,5,with,O
103293,5,severe,O
103293,5,asterixis,O
103293,5,and,O
103293,5,confusion,O
103293,5,.,O
103293,5,He,O
103293,5,had,O
103293,5,a,O
103293,5,number,O
103293,5,of,O
103293,5,potential,O
103293,5,causes,O
103293,5,such,O
103293,5,as,O
103293,5,medications,O
103293,5,",",O
103293,5,central,O
103293,5,focus,O
103293,5,with,O
103293,5,his,O
103293,5,SDH,O
103293,5,",",O
103293,5,and,O
103293,5,hypertension,O
103293,5,to,O
103293,5,180,O
103293,5,making,O
103293,5,PRES,O
103293,5,a,O
103293,5,less,O
103293,5,likely,O
103293,5,",",O
103293,5,but,O
103293,5,possible,O
103293,5,concern,O
103293,5,.,O
103293,5,Also,O
103293,5,",",O
103293,5,his,O
103293,5,uremia,O
103293,5,given,O
103293,5,his,O
103293,5,acute,O
103293,5,renal,O
103293,5,failure,O
103293,5,.,O
103293,5,He,O
103293,5,required,O
103293,5,several,O
103293,5,doses,O
103293,5,of,O
103293,5,Haldol,B-Drug
103293,5,and,O
103293,5,intermittent,O
103293,5,restraints,O
103293,5,for,O
103293,5,safety,O
103293,5,prior,O
103293,5,to,O
103293,5,intubation,O
103293,5,",",O
103293,5,when,O
103293,5,he,O
103293,5,was,O
103293,5,put,O
103293,5,on,O
103293,5,midazolam,B-Drug
103293,5,and,O
103293,6,Fentanyl,B-Drug
103293,6,drips,O
103293,6,.,O
103293,6,5,O
103293,6,days,O
103293,6,after,O
103293,6,intubation,O
103293,6,his,O
103293,6,was,O
103293,6,sedation,O
103293,6,was,O
103293,6,discontinued,O
103293,6,and,O
103293,6,he,O
103293,6,remained,O
103293,6,obtunded,O
103293,6,.,O
103293,6,He,O
103293,6,was,O
103293,6,treated,O
103293,6,with,O
103293,6,dialysis,O
103293,6,for,O
103293,6,a,O
103293,6,uremia,O
103293,6,over,O
103293,6,200,O
103293,6,.,O
103293,6,His,O
103293,6,mental,O
103293,6,status,O
103293,6,was,O
103293,6,the,O
103293,6,barrier,O
103293,6,to,O
103293,6,extubation,O
103293,6,as,O
103293,6,his,O
103293,6,vent,O
103293,6,setting,O
103293,6,were,O
103293,6,minimal,O
103293,6,at,O
103293,6,the,O
103293,6,point,O
103293,6,of,O
103293,6,weaning,O
103293,6,sedation,O
103293,6,.,O
103293,6,He,O
103293,6,was,O
103293,6,non,O
103293,6,responsive,O
103293,6,after,O
103293,6,4,O
103293,6,days,O
103293,6,off,O
103293,6,of,O
103293,6,sedation,O
103293,6,.,O
103293,6,A,O
103293,6,family,O
103293,6,meeting,O
103293,6,was,O
103293,6,held,O
103293,6,with,O
103293,6,his,O
103293,6,husband,O
103293,6,[,O
103293,6,**Name,O
103293,6,(,O
103293,6,NI,O
103293,6,),O
103293,6,**,O
103293,6,],O
103293,6,",",O
103293,6,and,O
103293,6,the,O
103293,6,decision,O
103293,6,was,O
103293,6,made,O
103293,6,to,O
103293,6,take,O
103293,6,him,O
103293,6,to,O
103293,6,trach,O
103293,6,",",O
103293,6,with,O
103293,6,the,O
103293,6,goal,O
103293,6,of,O
103293,6,trying,O
103293,6,to,O
103293,6,improve,O
103293,6,his,O
103293,6,mental,O
103293,6,status,O
103293,6,with,O
103293,6,dialysis,O
103293,6,.,O
103293,6,#,O
103293,6,Acute,O
103293,6,renal,O
103293,6,failure,O
103293,6,:,O
103293,6,His,O
103293,6,creatinine,O
103293,6,sharply,O
103293,6,rose,O
103293,6,from,O
103293,6,1.2,O
103293,6,on,O
103293,6,admission,O
103293,6,to,O
103293,6,a,O
103293,6,peak,O
103293,6,of,O
103293,6,4.9,O
103293,6,.,O
103293,6,This,O
103293,6,was,O
103293,6,thought,O
103293,6,to,O
103293,6,be,O
103293,6,in,O
103293,6,the,O
103293,6,setting,O
103293,6,of,O
103293,6,Tumor,O
103293,6,Lysis,O
103293,6,Syndrome,O
103293,6,(,O
103293,6,TLS,O
103293,6,),O
103293,6,and,O
103293,6,abdominal,O
103293,6,compartment,O
103293,6,syndrome,O
103293,6,.,O
103293,6,Also,O
103293,6,complicated,O
103293,6,by,O
103293,6,ATN,O
103293,6,in,O
103293,6,the,O
103293,6,setting,O
103293,6,of,O
103293,6,low,O
103293,6,blood,O
103293,6,volume,O
103293,6,and,O
103293,6,possible,O
103293,6,microthrombi,O
103293,6,during,O
103293,6,DIC,O
103293,6,.,O
103293,6,He,O
103293,6,was,O
103293,6,treated,O
103293,6,allopurinol,B-Drug
103293,6,and,O
103293,6,Rasburicase,B-Drug
103293,6,for,O
103293,6,TLS,B-Reason
103293,6,with,O
103293,6,good,O
103293,6,resolution,O
103293,6,as,O
103293,6,well,O
103293,6,as,O
103293,6,with,O
103293,6,CVVH,O
103293,6,initially,O
103293,6,(,O
103293,6,1,O
103293,6,day,O
103293,6,),O
103293,6,for,O
103293,6,fluid,O
103293,6,removal,O
103293,6,.,O
103293,6,His,O
103293,6,urine,O
103293,6,output,O
103293,6,responded,O
103293,6,.,O
103293,6,Shortly,O
103293,6,after,O
103293,6,he,O
103293,6,began,O
103293,6,autodiuresing,O
103293,6,He,O
103293,6,was,O
103293,6,initiated,O
103293,6,on,O
103293,6,dialysis,O
103293,6,for,O
103293,6,AMS,O
103293,6,as,O
103293,6,described,O
103293,6,above,O
103293,6,and,O
103293,6,a,O
103293,6,BUN,O
103293,6,of,O
103293,6,greater,O
103293,6,than,O
103293,6,200,O
103293,6,.,O
103293,6,He,O
103293,6,was,O
103293,6,treated,O
103293,6,with,O
103293,6,dialysis,O
103293,6,with,O
103293,6,a,O
103293,6,fall,O
103293,6,in,O
103293,6,BUN,O
103293,6,to,O
103293,6,113,O
103293,6,",",O
103293,6,however,O
103293,6,",",O
103293,6,he,O
103293,6,had,O
103293,6,a,O
103293,6,fever,O
103293,6,to,O
103293,6,100.6,O
103293,6,and,O
103293,6,cultures,O
103293,6,came,O
103293,6,back,O
103293,6,positive,O
103293,6,for,O
103293,6,GPC,O
103293,6,in,O
103293,6,chains,O
103293,6,from,O
103293,6,dialysis,O
103293,6,catheter,O
103293,6,[,O
103293,6,**2174-4-9**,O
103293,6,],O
103293,6,.,O
103293,6,.,O
103293,6,#,O
103293,6,Abdominal,O
103293,6,Compartment,O
103293,6,Syndrome,O
103293,6,:,O
103293,6,In,O
103293,6,the,O
103293,6,setting,O
103293,6,of,O
103293,6,acute,O
103293,6,volume,O
103293,6,overload,O
103293,6,from,O
103293,6,large,O
103293,6,volume,O
103293,6,transfusions,O
103293,6,given,O
103293,6,DIC,O
103293,6,as,O
103293,6,above,O
103293,6,.,O
103293,6,He,O
103293,6,was,O
103293,6,~25L,O
103293,6,positive,O
103293,6,for,O
103293,6,LOS,O
103293,6,fluid,O
103293,6,balance,O
103293,6,.,O
103293,6,He,O
103293,6,developed,O
103293,6,elevated,O
103293,6,bladder,O
103293,6,pressures,O
103293,6,and,O
103293,6,decreased,O
103293,6,urine,O
103293,6,output,O
103293,6,.,O
103293,6,Surgery,O
103293,6,was,O
103293,6,consulted,O
103293,6,and,O
103293,6,felt,O
103293,6,that,O
103293,6,as,O
103293,6,long,O
103293,6,as,O
103293,6,he,O
103293,6,was,O
103293,6,making,O
103293,6,urine,O
103293,7,there,O
103293,7,was,O
103293,7,no,O
103293,7,need,O
103293,7,for,O
103293,7,surgical,O
103293,7,intervention,O
103293,7,(,O
103293,7,as,O
103293,7,well,O
103293,7,as,O
103293,7,given,O
103293,7,his,O
103293,7,critical,O
103293,7,illness,O
103293,7,",",O
103293,7,it,O
103293,7,was,O
103293,7,not,O
103293,7,indicated,O
103293,7,),O
103293,7,.,O
103293,7,He,O
103293,7,was,O
103293,7,started,O
103293,7,on,O
103293,7,CVVH,O
103293,7,as,O
103293,7,above,O
103293,7,and,O
103293,7,had,O
103293,7,3L,O
103293,7,removed,O
103293,7,.,O
103293,7,His,O
103293,7,kidneys,O
103293,7,responded,O
103293,7,and,O
103293,7,began,O
103293,7,making,O
103293,7,100-200cc/hr,O
103293,7,of,O
103293,7,urine,O
103293,7,.,O
103293,7,His,O
103293,7,CVVH,O
103293,7,was,O
103293,7,stopped,O
103293,7,and,O
103293,7,he,O
103293,7,was,O
103293,7,allowed,O
103293,7,to,O
103293,7,diurese,B-Reason
103293,7,on,O
103293,7,his,O
103293,7,own,O
103293,7,with,O
103293,7,support,O
103293,7,of,O
103293,7,lasix,B-Drug
103293,7,and,O
103293,7,metolazone,B-Drug
103293,7,as,O
103293,7,needed,O
103293,7,.,O
103293,7,.,O
103293,7,#,O
103293,7,Atrial,O
103293,7,Fibrillation,O
103293,7,/,O
103293,7,Flutter,O
103293,7,:,O
103293,7,He,O
103293,7,developed,O
103293,7,tachycardia,O
103293,7,to,O
103293,7,the,O
103293,7,140s,O
103293,7,with,O
103293,7,initial,O
103293,7,EKG,O
103293,7,most,O
103293,7,consistent,O
103293,7,with,O
103293,7,Afib,O
103293,7,",",O
103293,7,and,O
103293,7,later,O
103293,7,EKG,O
103293,7,more,O
103293,7,consistent,O
103293,7,with,O
103293,7,Aflutter,O
103293,7,vs,O
103293,7,AVNRT,O
103293,7,.,O
103293,7,His,O
103293,7,HR,O
103293,7,did,O
103293,7,not,O
103293,7,respond,O
103293,7,to,O
103293,7,Diltiazem,B-Drug
103293,7,drip,O
103293,7,or,O
103293,7,multiple,O
103293,7,subsequent,O
103293,7,IV,O
103293,7,boluses,O
103293,7,of,O
103293,7,Diltiazem,B-Drug
103293,7,and,O
103293,7,Metoprolol,B-Drug
103293,7,.,O
103293,7,Cardiology,O
103293,7,suggested,O
103293,7,Verapamil,B-Drug
103293,7,",",O
103293,7,followed,O
103293,7,by,O
103293,7,Amiodarone,B-Drug
103293,7,.,O
103293,7,He,O
103293,7,was,O
103293,7,loaded,O
103293,7,with,O
103293,7,Amiodarone,B-Drug
103293,7,drip,O
103293,7,and,O
103293,7,bolus,O
103293,7,of,O
103293,7,150,O
103293,7,mg,O
103293,7,x2,O
103293,7,.,O
103293,7,He,O
103293,7,was,O
103293,7,cardioverted,O
103293,7,on,O
103293,7,[,O
103293,7,**2174-3-22**,O
103293,7,],O
103293,7,and,O
103293,7,continued,O
103293,7,on,O
103293,7,Amiodarone,B-Drug
103293,7,.,O
103293,7,He,O
103293,7,got,O
103293,7,an,O
103293,7,extra,O
103293,7,150mg,O
103293,7,of,O
103293,7,amiodarone,B-Drug
103293,7,on,O
103293,7,[,O
103293,7,**3-25**,O
103293,7,],O
103293,7,with,O
103293,7,minimal,O
103293,7,effect,O
103293,7,on,O
103293,7,tachycardia,O
103293,7,.,O
103293,7,He,O
103293,7,converted,O
103293,7,to,O
103293,7,NSR,O
103293,7,",",O
103293,7,and,O
103293,7,reverted,O
103293,7,back,O
103293,7,to,O
103293,7,atrial,O
103293,7,fibrillation,O
103293,7,.,O
103293,7,In,O
103293,7,the,O
103293,7,setting,O
103293,7,of,O
103293,7,controlling,O
103293,7,his,O
103293,7,blood,B-Reason
103293,7,pressure,I-Reason
103293,7,with,O
103293,7,IV,O
103293,7,medications,O
103293,7,he,O
103293,7,received,O
103293,7,multiple,O
103293,7,doses,O
103293,7,of,O
103293,7,metoprolol,B-Drug
103293,7,and,O
103293,7,labetalol,B-Drug
103293,7,",",O
103293,7,and,O
103293,7,he,O
103293,7,converted,O
103293,7,to,O
103293,7,NSR,O
103293,7,.,O
103293,7,However,O
103293,7,",",O
103293,7,[,O
103293,7,**4-1**,O
103293,7,],O
103293,7,he,O
103293,7,converted,O
103293,7,back,O
103293,7,to,O
103293,7,rapid,O
103293,7,a-fib,O
103293,7,with,O
103293,7,RVR,O
103293,7,and,O
103293,7,required,O
103293,7,uptitration,O
103293,7,of,O
103293,7,his,O
103293,7,B-blockade,B-Drug
103293,7,and,O
103293,7,a,O
103293,7,diltiazem,B-Drug
103293,7,drip,O
103293,7,which,O
103293,7,was,O
103293,7,eventually,O
103293,7,converted,O
103293,7,back,O
103293,7,to,O
103293,7,PO,O
103293,7,.,O
103293,7,.,O
103293,7,#,O
103293,7,Bilateral,B-Reason
103293,7,Subdural,I-Reason
103293,7,Hematomas,I-Reason
103293,7,:,O
103293,7,Unclear,O
103293,7,time,O
103293,7,course,O
103293,7,.,O
103293,7,Neurosurgery,O
103293,7,followed,O
103293,7,along,O
103293,7,and,O
103293,7,he,O
103293,7,had,O
103293,7,serial,O
103293,7,scans,O
103293,7,.,O
103293,7,His,O
103293,7,hematomas,O
103293,7,had,O
103293,7,interval,O
103293,7,increased,O
103293,7,in,O
103293,7,the,O
103293,7,setting,O
103293,7,of,O
103293,7,the,O
103293,7,DIC,O
103293,7,;,O
103293,7,however,O
103293,7,",",O
103293,7,not,O
103293,7,thought,O
103293,7,to,O
103293,7,be,O
103293,7,clinically,O
103293,7,significant,O
103293,7,.,O
103293,7,Neurosurgery,O
103293,7,preferred,O
103293,7,medical,O
103293,7,management,O
103293,7,with,O
103293,7,antiepileptics,B-Drug
103293,7,and,O
103293,7,reversal,O
103293,7,of,O
103293,7,his,O
103293,7,coagulopathy,O
103293,7,.,O
103293,7,.,O
103293,7,#,O
103293,7,Right,O
103293,7,basal,O
103293,7,ganglia,O
103293,7,infarct,O
103293,7,:,O
103293,7,On,O
103293,7,repeat,O
103293,7,scan,O
103293,7,of,O
103293,7,his,O
103293,7,head,O
103293,7,to,O
103293,8,evaluate,O
103293,8,interval,O
103293,8,change,O
103293,8,of,O
103293,8,his,O
103293,8,subdural,O
103293,8,hematomas,O
103293,8,on,O
103293,8,[,O
103293,8,**2174-4-4**,O
103293,8,],O
103293,8,",",O
103293,8,a,O
103293,8,new,O
103293,8,right,O
103293,8,sided,O
103293,8,basal,O
103293,8,ganglia,O
103293,8,infarct,O
103293,8,was,O
103293,8,noted,O
103293,8,.,O
103293,8,Neurosurgery,O
103293,8,followed,O
103293,8,",",O
103293,8,and,O
103293,8,neurology,O
103293,8,was,O
103293,8,consulted,O
103293,8,.,O
103293,8,They,O
103293,8,felt,O
103293,8,that,O
103293,8,medical,O
103293,8,management,O
103293,8,and,O
103293,8,blood,O
103293,8,pressure,O
103293,8,control,O
103293,8,were,O
103293,8,the,O
103293,8,best,O
103293,8,means,O
103293,8,of,O
103293,8,treatment,O
103293,8,.,O
103293,8,.,O
103293,8,#,O
103293,8,Positive,B-Reason
103293,8,Blood,I-Reason
103293,8,Cultures,I-Reason
103293,8,:,O
103293,8,Blood,O
103293,8,cultures,O
103293,8,were,O
103293,8,positive,O
103293,8,in,O
103293,8,[,O
103293,8,**2-16**,O
103293,8,],O
103293,8,bottles,O
103293,8,from,O
103293,8,his,O
103293,8,PICC,O
103293,8,line,O
103293,8,on,O
103293,8,[,O
103293,8,**2174-3-22**,O
103293,8,],O
103293,8,.,O
103293,8,The,O
103293,8,aerobic,O
103293,8,culture,O
103293,8,was,O
103293,8,speciated,O
103293,8,as,O
103293,8,Staph,O
103293,8,aureus,O
103293,8,.,O
103293,8,No,O
103293,8,peripheral,O
103293,8,culture,O
103293,8,was,O
103293,8,obtained,O
103293,8,on,O
103293,8,that,O
103293,8,date,O
103293,8,.,O
103293,8,He,O
103293,8,was,O
103293,8,started,O
103293,8,on,O
103293,8,Vancomycin,B-Drug
103293,8,/,O
103293,8,Meropenem,B-Drug
103293,8,on,O
103293,8,[,O
103293,8,**2174-3-22**,O
103293,8,],O
103293,8,after,O
103293,8,spiking,O
103293,8,a,O
103293,8,fever,O
103293,8,to,O
103293,8,102.5,O
103293,8,.,O
103293,8,This,O
103293,8,was,O
103293,8,changed,O
103293,8,to,O
103293,8,Vancomycin,B-Drug
103293,8,/,O
103293,8,Cefepime,B-Drug
103293,8,the,O
103293,8,next,O
103293,8,day,O
103293,8,.,O
103293,8,Given,O
103293,8,the,O
103293,8,concern,O
103293,8,for,O
103293,8,translocation,O
103293,8,of,O
103293,8,gut,O
103293,8,bacteria,O
103293,8,with,O
103293,8,his,O
103293,8,compromised,O
103293,8,immune,O
103293,8,system,O
103293,8,",",O
103293,8,he,O
103293,8,was,O
103293,8,switched,O
103293,8,to,O
103293,8,Vancomycin,B-Drug
103293,8,/,O
103293,8,Zosyn,B-Drug
103293,8,on,O
103293,8,[,O
103293,8,**2174-3-24**,O
103293,8,],O
103293,8,for,O
103293,8,better,B-Reason
103293,8,coverage,I-Reason
103293,8,of,I-Reason
103293,8,gut,I-Reason
103293,8,pathogens,I-Reason
103293,8,.,O
103293,8,Micafungin,B-Drug
103293,8,was,O
103293,8,added,O
103293,8,to,O
103293,8,cover,O
103293,8,for,O
103293,8,fungal,B-Reason
103293,8,pathogens,I-Reason
103293,8,.,O
103293,8,He,O
103293,8,had,O
103293,8,multiple,O
103293,8,sets,O
103293,8,of,O
103293,8,negative,O
103293,8,surveillance,O
103293,8,cultures,O
103293,8,",",O
103293,8,and,O
103293,8,his,O
103293,8,antibiotics,B-Drug
103293,8,were,O
103293,8,continued,O
103293,8,while,O
103293,8,he,O
103293,8,remained,O
103293,8,neutropenic,O
103293,8,.,O
103293,8,He,O
103293,8,had,O
103293,8,a,O
103293,8,fever,O
103293,8,to,O
103293,8,100.6,O
103293,8,on,O
103293,8,[,O
103293,8,**2174-4-9**,O
103293,8,],O
103293,8,and,O
103293,8,cultures,O
103293,8,were,O
103293,8,drawn,O
103293,8,from,O
103293,8,his,O
103293,8,dialysis,O
103293,8,catheter,O
103293,8,which,O
103293,8,were,O
103293,8,positive,O
103293,8,for,O
103293,8,GPCs,B-Reason
103293,8,in,I-Reason
103293,8,chains,I-Reason
103293,8,.,O
103293,8,His,O
103293,8,catheter,O
103293,8,was,O
103293,8,pulled,O
103293,8,and,O
103293,8,he,O
103293,8,was,O
103293,8,continued,O
103293,8,on,O
103293,8,vancomycin,B-Drug
103293,8,.,O
103293,8,.,O
103293,8,#,O
103293,8,Pericardial,O
103293,8,Fat,O
103293,8,Pad,O
103293,8,:,O
103293,8,On,O
103293,8,echo,O
103293,8,on,O
103293,8,[,O
103293,8,**2174-3-24**,O
103293,8,],O
103293,8,there,O
103293,8,was,O
103293,8,concern,O
103293,8,for,O
103293,8,pericardial,O
103293,8,effusion,O
103293,8,because,O
103293,8,the,O
103293,8,echo,O
103293,8,showed,O
103293,8,a,O
103293,8,new,O
103293,8,anterior,O
103293,8,pericardial,O
103293,8,effusion,O
103293,8,with,O
103293,8,complex,O
103293,8,echodensity,O
103293,8,.,O
103293,8,No,O
103293,8,evidence,O
103293,8,of,O
103293,8,tamponade,O
103293,8,physiology,O
103293,8,was,O
103293,8,seen,O
103293,8,on,O
103293,8,the,O
103293,8,echo,O
103293,8,.,O
103293,8,His,O
103293,8,repeat,O
103293,8,echo,O
103293,8,showed,O
103293,8,that,O
103293,8,the,O
103293,8,effusion,O
103293,8,was,O
103293,8,actually,O
103293,8,a,O
103293,8,fat,O
103293,8,pad,O
103293,8,.,O
103293,8,.,O
103293,8,#,O
103293,8,Alcoholism/Cirrhosis,O
103293,8,:,O
103293,8,He,O
103293,8,was,O
103293,8,known,O
103293,8,to,O
103293,8,drink,O
103293,8,a,O
103293,8,bottle,O
103293,8,of,O
103293,8,alcohol,O
103293,8,per,O
103293,8,night,O
103293,8,.,O
103293,8,He,O
103293,8,initially,O
103293,8,required,O
103293,8,10,O
103293,8,mg,O
103293,8,IV,O
103293,8,diazepam,B-Drug
103293,8,several,O
103293,8,times,O
103293,8,and,O
103293,8,started,O
103293,8,on,O
103293,8,a,O
103293,8,CIWA,O
103293,8,scale,O
103293,9,.,O
103293,9,On,O
103293,9,RUQ,O
103293,9,imaging,O
103293,9,for,O
103293,9,persistent,O
103293,9,elevation,O
103293,9,of,O
103293,9,his,O
103293,9,bilirubin,O
103293,9,",",O
103293,9,cirrhosis,O
103293,9,was,O
103293,9,noted,O
103293,9,.,O
103293,9,More,O
103293,9,than,O
103293,9,likely,O
103293,9,his,O
103293,9,cirrhosis,O
103293,9,was,O
103293,9,secondary,O
103293,9,to,O
103293,9,alcoholism,O
103293,9,and,O
103293,9,he,O
103293,9,had,O
103293,9,poor,O
103293,9,clearance,O
103293,9,of,O
103293,9,his,O
103293,9,bilirubin,O
103293,9,(,O
103293,9,from,O
103293,9,reabsorption,O
103293,9,from,O
103293,9,pooled,O
103293,9,blood,O
103293,9,),O
103293,9,.,O
103293,9,.,O
103293,9,#,O
103293,9,Elevated,B-ADE
103293,9,Glucose,I-ADE
103293,9,:,O
103293,9,He,O
103293,9,initially,O
103293,9,had,O
103293,9,glucose,O
103293,9,'s,O
103293,9,in,O
103293,9,the,O
103293,9,400,O
103293,9,?,O
103293,9,?,O
103293,9,?,O
103293,9,?,O
103293,9,?,O
103293,9,?,O
103293,9,s,O
103293,9,in,O
103293,9,the,O
103293,9,setting,O
103293,9,of,O
103293,9,getting,O
103293,9,steroids,B-Drug
103293,9,.,O
103293,9,His,O
103293,9,insulin,B-Drug
103293,9,coverage,O
103293,9,was,O
103293,9,briefly,O
103293,9,switched,O
103293,9,to,O
103293,9,an,O
103293,9,insulin,B-Drug
103293,9,drip,O
103293,9,",",O
103293,9,and,O
103293,9,he,O
103293,9,was,O
103293,9,subsequently,O
103293,9,converted,O
103293,9,to,O
103293,9,subcutaneous,O
103293,9,insulin,B-Drug
103293,9,based,O
103293,9,on,O
103293,9,his,O
103293,9,requirements,O
103293,9,.,O
103293,9,#,O
103293,9,Goals,O
103293,9,of,O
103293,9,care,O
103293,9,:,O
103293,9,Pt,O
103293,9,remained,O
103293,9,in,O
103293,9,coma,O
103293,9,.,O
103293,9,His,O
103293,9,overall,O
103293,9,clinical,O
103293,9,status,O
103293,9,continued,O
103293,9,to,O
103293,9,decline,O
103293,9,over,O
103293,9,the,O
103293,9,course,O
103293,9,of,O
103293,9,hospitalization,O
103293,9,",",O
103293,9,with,O
103293,9,evolution,O
103293,9,of,O
103293,9,multi-system,O
103293,9,organ,O
103293,9,failure,O
103293,9,including,O
103293,9,increased,O
103293,9,pulmonary,O
103293,9,ventilatory,O
103293,9,requirements,O
103293,9,",",O
103293,9,persistant,O
103293,9,renal,O
103293,9,failure,O
103293,9,",",O
103293,9,LFTs,O
103293,9,continued,O
103293,9,to,O
103293,9,increase,O
103293,9,and,O
103293,9,he,O
103293,9,developed,O
103293,9,recurrent,O
103293,9,bacteremia,O
103293,9,(,O
103293,9,initially,O
103293,9,MSSA,O
103293,9,",",O
103293,9,then,O
103293,9,VRE,O
103293,9,),O
103293,9,.,O
103293,9,He,O
103293,9,was,O
103293,9,given,O
103293,9,1,O
103293,9,dose,O
103293,9,of,O
103293,9,daptomycin,B-Drug
103293,9,for,O
103293,9,VRE,B-Reason
103293,9,coverage,I-Reason
103293,9,.,O
103293,9,Given,O
103293,9,his,O
103293,9,multiple,O
103293,9,organ,O
103293,9,failure,O
103293,9,",",O
103293,9,worsening,O
103293,9,ventilatory,O
103293,9,requirements,O
103293,9,and,O
103293,9,persistent,O
103293,9,altered,O
103293,9,mental,O
103293,9,status,O
103293,9,",",O
103293,9,a,O
103293,9,family,O
103293,9,meeting,O
103293,9,was,O
103293,9,held,O
103293,9,and,O
103293,9,decision,O
103293,9,made,O
103293,9,to,O
103293,9,focus,O
103293,9,efforts,O
103293,9,on,O
103293,9,patient,O
103293,9,comfort,O
103293,9,beginning,O
103293,9,[,O
103293,9,**2174-4-12**,O
103293,9,],O
103293,9,AM,O
103293,9,.,O
103293,9,The,O
103293,9,patient,O
103293,9,quietly,O
103293,9,expired,O
103293,9,on,O
103293,9,[,O
103293,9,**2174-4-14**,O
103293,9,],O
103293,9,with,O
103293,9,family,O
103293,9,at,O
103293,9,the,O
103293,9,bedside,O
103293,9,.,O
103293,9,Medications,O
103293,9,on,O
103293,9,Admission,O
103293,9,:,O
103293,9,-,O
103293,9,Metformin,B-Drug
103293,9,500mg,O
103293,9,[,O
103293,9,**Hospital1,O
103293,9,**,O
103293,9,],O
103293,9,-,O
103293,9,Metoprolol,B-Drug
103293,9,tartrate,I-Drug
103293,9,50mg,O
103293,9,[,O
103293,9,**Hospital1,O
103293,9,**,O
103293,9,],O
103293,9,-,O
103293,9,Cimetidine,B-Drug
103293,9,100mg,O
103293,9,[,O
103293,9,**Hospital1,O
103293,9,**,O
103293,9,],O
103293,9,-,O
103293,9,Amlodipine,B-Drug
103293,9,10mg,O
103293,9,daily,O
103293,9,-,O
103293,9,Lisinopril,B-Drug
103293,9,2.5mg,O
103293,9,daily,O
103293,9,Discharge,O
103293,9,Medications,O
103293,9,:,O
103293,9,Deceased,O
103293,9,Discharge,O
103293,9,Disposition,O
103293,9,:,O
103293,9,Expired,O
103293,9,Discharge,O
103293,9,Diagnosis,O
103293,9,:,O
103293,9,Deceased,O
103293,9,Discharge,O
103293,9,Condition,O
103293,9,:,O
103293,9,Deceased,O
103293,9,Discharge,O
103293,9,Instructions,O
103293,9,:,O
103293,9,Deceased,O
103293,9,Followup,O
103293,9,Instructions,O
103293,9,:,O
103293,9,Deceased,O
103293,9,[,O
103293,9,**First,O
103293,9,Name8,O
103293,9,(,O
103293,9,NamePattern2,O
103293,9,),O
103293,9,**,O
103293,9,],O
103293,9,[,O
103293,9,**Last,O
103293,9,Name,O
103293,9,(,O
103293,9,NamePattern1,O
103293,9,),O
103293,9,2437**,O
103293,9,],O
103293,9,MD,O
103293,9,[,O
103293,9,**MD,O
103293,9,Number,O
103293,9,(,O
103293,9,1,O
103293,9,),O
103293,9,2438**,O
103293,9,],O
